| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 06/19/2013 | CN101678214B 芳基醚哒嗪酮衍生物 Aryl ether pyridazinones |
| 06/19/2013 | CN101677567B A synergistic pharmaceutical combination for the treatment of cancer |
| 06/19/2013 | CN101669973B Biological immunopotentiator composition for treating cancers |
| 06/19/2013 | CN101652374B Anhydrous crystalline vinflunine salts, method of preparation and use thereof as a drug and means of vinflunine purification |
| 06/19/2013 | CN101627027B 氨基吡唑激酶抑制剂 Aminopyrazole kinase inhibitors |
| 06/19/2013 | CN101605764B Fast dissociating dopamine 2 receptor antagonists |
| 06/19/2013 | CN101602730B Substituted imidazole derivative |
| 06/19/2013 | CN101595088B Benzylamine derivative or pharmaceutically acceptable acid addition salt thereof, and use thereof for medical purposes |
| 06/19/2013 | CN101594871B Pyrrolopyrimidine compounds and their uses |
| 06/19/2013 | CN101583605B Triazole derivative as an HSP 90 inhibitor |
| 06/19/2013 | CN101578271B 4-imidazolines as taar's ligands |
| 06/19/2013 | CN101574333B Allitride composition and method for preparing drop therewith for treating nasal cavity infected by microbes and application thereof |
| 06/19/2013 | CN101550136B Diarylurea derivatives and application thereof used for preparing anti-neoplastic medicament |
| 06/19/2013 | CN101511343B Use of polyols to obtain stable polymorphous forms of rifaximin |
| 06/19/2013 | CN101505608B Polyphenol/peptide composition |
| 06/19/2013 | CN101486701B Analogue compound, and analogue and medical use thereof |
| 06/19/2013 | CN101486700B 8-acetyl chromanone compound, and analogue and medical use thereof |
| 06/19/2013 | CN101466835B Method for controlling the amount of gene product, and agent for controlling the amount of gene product |
| 06/19/2013 | CN101454048B Sulphated hyaluronic acid for treating degenerative osteoarthritis |
| 06/19/2013 | CN101450939B Novel benzimidazoles compounds |
| 06/19/2013 | CN101437944B Short interfering ribonucleic acid (siRNA) for oral administration |
| 06/19/2013 | CN101437819B Pyridopyrazines and derivatives thereof as alk and c-MET inhibitors |
| 06/19/2013 | CN101432005B Polymer-based anti-cancer agents |
| 06/19/2013 | CN101422443B Fenofibrate osmotic pump controlled release preparation and preparation method thereof |
| 06/19/2013 | CN101411711B Composition containing alisol A and alisol A 24-acetic ester and use |
| 06/19/2013 | CN101407456B Effective ingredient having beta-secretase inhibition effect in Homalonema occulta |
| 06/19/2013 | CN101390815B Topical use of thiazolidine derivatives against the consequences of oxidising stress of the skin |
| 06/19/2013 | CN101374509B Use of beta-hydroxy-beta-methylbutyrate to modulate the imbalance in type 1 and type 2 cytokine production |
| 06/19/2013 | CN101305990B Use of EDG receptor binding agents in cancer |
| 06/19/2013 | CN101293016B Application of cistanche salsa extract in preparing medicament for treating parkinsonism |
| 06/19/2013 | CN101260063B Gamma-aminobutyric acid derivative and its preparing process |
| 06/19/2013 | CN101252924B Methods and compositions for treating ophthalmic conditions via serum retinol, serum retinol binding protein (RBP), and/or serum retinol-RBP modulation |
| 06/19/2013 | CN101224228B Panax notoginseng saponins freeze-dried powder injection and preparing method thereof |
| 06/19/2013 | CN101214227B Ambroxol hydrochloride dry powder inhalant and preparation thereof |
| 06/19/2013 | CN101107234B HIV inhibiting 2-(4-cyanophenylamino) pyrimidine derivatives |
| 06/19/2013 | CN101072759B Triazole compounds that modulate HSP90 activity |
| 06/18/2013 | USRE44302 N-acetyl aldosamines, N-acetylamino acids and related N-acetyl compounds and their topical use |
| 06/18/2013 | US8466316 Polymorphic form of N-(S)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydroxypropyl)cyclopropane-1-sulfonamide and uses thereof |
| 06/18/2013 | US8466295 Thiophene derivatives as factor XIa inhibitors |
| 06/18/2013 | US8466294 1-aza-3,7-dioxabicyclo[3.3.0]octane compounds and their use as pro-fragrances |
| 06/18/2013 | US8466292 5,6-bisaryl-2-pyridine-carboxamide derivatives, preparation thereof and therapeutic application thereof as urotensin II receptor antagonists |
| 06/18/2013 | US8466291 1,5-dideoxy-1,5-imino-D-glucitol compounds |
| 06/18/2013 | US8466289 Heterocyclic sulfonamide derivatives |
| 06/18/2013 | US8466288 Isoindolinone inhibitors of phosphatidylinositol 3-kinase |
| 06/18/2013 | US8466282 Heterocyclic compound and use thereof |
| 06/18/2013 | US8466281 2,5-disubstituted morpholine orexin receptor antagonists |
| 06/18/2013 | US8466280 Co-crystal compound of rivaroxaban and malonic acid |
| 06/18/2013 | US8466278 Carboxyethylated cyclodextrin polysulfates useful as medicaments |
| 06/18/2013 | US8466277 Coupling low-molecular substances to a modified polysaccharide |
| 06/18/2013 | US8466276 Oligomer conjugates of heteropentacyclic nucleosides |
| 06/18/2013 | US8466203 Method of stabilizing human eye tissue by reaction with nitrite and related agents such as nitro compounds |
| 06/18/2013 | US8466202 Anthracenedione compounds |
| 06/18/2013 | US8466201 Potassium ion channel modulators and uses thereof |
| 06/18/2013 | US8466200 2-adamantylurea derivatives as selective 11β-HSD1 inhibitors |
| 06/18/2013 | US8466199 Allyloxy and alkyloxy benzoic acid delivery agents |
| 06/18/2013 | US8466197 Thiocarbonates as anti-inflammatory and antioxidant compounds useful for treating metabolic disorders |
| 06/18/2013 | US8466196 Acetals as perfuming ingredients |
| 06/18/2013 | US8466195 Methods and compositions for treating complications of diabetes and vascular diseases using flavones |
| 06/18/2013 | US8466192 Use of sarmentine and its analogs for controlling plant pests |
| 06/18/2013 | US8466191 Pyrroline derivatives against cell releasing tumor necrosis factor, preparation methods and uses thereof |
| 06/18/2013 | US8466190 Polymorphic forms of Sunitinib base |
| 06/18/2013 | US8466189 N-alkoxylated 2,3-anthraquinonedicarboximides for polymer coloration, preparation and use |
| 06/18/2013 | US8466188 Use of spiro-oxindole compounds as therapeutic agents |
| 06/18/2013 | US8466187 Amino acid compositions |
| 06/18/2013 | US8466186 Compounds |
| 06/18/2013 | US8466185 Methods and assays for detecting and treating hypoglycemia |
| 06/18/2013 | US8466183 Modulators of sphingosine phosphate receptors |
| 06/18/2013 | US8466182 Small molecule inhibitors of kynurenine-3-monooxygenase |
| 06/18/2013 | US8466179 Methods of preparing pre-mixed, ready-to-use pharmaceutical compositions |
| 06/18/2013 | US8466178 Pre-mixed, ready-to-use pharmaceutical compositions |
| 06/18/2013 | US8466177 Treating and preventing viral infections |
| 06/18/2013 | US8466175 Form of S-omeprazole |
| 06/18/2013 | US8466174 Methods for stabilizing oxidatively unstable compositions |
| 06/18/2013 | US8466173 Crystal forms of (3R)-1-(2-methylalanyl-D-tryptophyl)-3-(phenylmethyl)-3-piperidinecarboxylic acid 1,2,2-trimethylhydrazide |
| 06/18/2013 | US8466172 Stabilization of hypoxia inducible factor (HIF) alpha |
| 06/18/2013 | US8466171 Fused heterocyclic compounds useful as modulators of nuclear hormone receptor function |
| 06/18/2013 | US8466170 7-azaindole derivatives |
| 06/18/2013 | US8466169 SF5 derivatives as PAR1 inhibitors, production thereof, and use as medicaments |
| 06/18/2013 | US8466167 Compounds and compositions as TLR activity modulators |
| 06/18/2013 | US8466166 Benzimidazole derivatives as selective acid pump inhibitors |
| 06/18/2013 | US8466165 4-phenylamino-quinazolin-6-yl-amides |
| 06/18/2013 | US8466164 4-substituted derivatives of pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine and uses thereof |
| 06/18/2013 | US8466163 Furo[2,3-d]pyrimidines and related compounds and methods for treating disease states by inhibiting tubulin polymerization |
| 06/18/2013 | US8466161 Hydroxamate derivative, a production method for the same, and a pharmaceutical composition comprising the same |
| 06/18/2013 | US8466159 Methods for treating HCV |
| 06/18/2013 | US8466158 Cysteine protease inhibitors |
| 06/18/2013 | US8466157 Proteasome inhibitors having chymotrypsin-like activity |
| 06/18/2013 | US8466156 2-phenyl-4-cyclopropyl-pyrimidine derivatives |
| 06/18/2013 | US8466155 Pyrimidines |
| 06/18/2013 | US8466154 Methods and compositions related to wrapping of dehydrons |
| 06/18/2013 | US8466153 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists |
| 06/18/2013 | US8466152 (aza)indole derivative and use thereof for medical purposes |
| 06/18/2013 | US8466151 Compounds and method for treatment of cancer |
| 06/18/2013 | US8466150 Such as 7-((cyclohexyl)methyl) pyrido(2,3-d )pyridazine-4(5H)-one; anticancer agents; antiinflammatory agents;antiischemic agents; antidiabetic agents |
| 06/18/2013 | US8466149 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I |
| 06/18/2013 | US8466148 1,2-disubstituted heterocyclic compounds |
| 06/18/2013 | US8466147 Use of reversine and analogs for treatment of cancer |
| 06/18/2013 | US8466146 Cyclothiocarbamate derivatives as progesterone receptor modulators |
| 06/18/2013 | US8466145 Dipeptidyl peptidase IV inhibitors |
| 06/18/2013 | US8466144 Muscarinic antagonists with parp and sir modulating activity as cytoprotective agents |